Syndion Product Information

Email
Sign up here to receive promotional offers
and news about Syndion products.
Share    
Syndion Logo

For Healthcare Professionals

2011 Articles of Interest: 


  • Nutritional and Metabolic Status of Children with Autism vs. Neurotypical Children, and the Association with Autism Severity
    Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W. Nutrition & Metabolism 2011, 8:34 doi:10.1186/1743-7075-8-34.  Published: 8 June 2011.
    "The autism group had many statistically significant differences in their nutritional and metabolic status, including biomarkers indicative of vitamin insufficiency, increased oxidative stress, reduced capacity for energy transport, sulfation and detoxification. Several of the biomarker groups were significantly associated with variations in the severity of autism. These nutritional and metabolic differences are generally in agreement with other published results and are likely amenable to nutritional supplementation. Research investigating treatment and its relationship to the co-morbidities and etiology of autism is warranted."
  • Prenatal vitamins, one-carbon metabolism gene variants and risk for autism. Schmidt, RJ, RL Hansen, J Hartiala, H Allayee, LC Schmidt, DC Tracredi, F Tassone and I Hertz-Picciotto. 2011.  Epidemiology: July 2011 - Volume 22 - Issue 4 - pp 476-485.
  • Dietary Choline Intake by Children with Autism Is below the Recommended Dietary Reference Intake (DRI) Established by the IOM.James, SJ, Pauly M, Melnyk S, Stewart PA, Schmidt BL, Lemcke N, Reynolds AM, Molloy CA, Johnson C, Clemons T, Hyman SL.International Meeting for Autism Research (IMFAR) 2011 May 12. 
    “The low dietary intake of choline and betaine in children with autism may contribute to reduced methylation capacity in some children with autism.”
  • Nutrient Intake and Supplement Use In Children with Autism Spectrum Disorders: Do Multivitamins Provide the Nutrients Consumed In Low Amounts? Stewart PA, Schmidt BL, Lemcke N, Wixom N, Clemons T, Peck R, Foley J, Hyman SL.  International Meeting for Autism Research (IMFAR) 2011 May 12. 
    “Many children with ASD do not meet recommended intakes for nutrients.”
  • Glutathione Redox Imbalance and Increased DNA Oxidation In Specific Brain Regions In AutismChauhan A,  Audhya T,  Chauhan V. International Meeting for Autism Research (IMFAR) 2011 May 12. 
    “A decrease in reduced glutathione (GSH), an increase in its oxidized form (GSSG) and a decrease in redox ratio of GSH/GSSG in cerebellum and temporal cortex in autism subjects, but not in other brain regions suggest brain region-specific glutathione redox imbalance in autism. Increase in DNA oxidation in frontal cortex, temporal cortex and cerebellum in autism but not in parietal and occipital cortex further confirms that oxidative stress differentially affects selective brain regions in autism. These results indicate increased oxidative damage coupled with reduced antioxidant status in the brain of individuals with autism.”
  • A Randomized Controlled Double-Blind Trila of N-Acetylcysteine in Children with Autism. Hardan AY,  Fung LK, Libove RA, Obukhanych VT, Nair S, Frazier WT, Herzenberg L, Tirouvanziam R.   International Meeting for Autism Research (IMFAR) 2011 May 12. 
    “NAC was overall well-tolerated with limited side effects. Compared to placebo, NAC resulted in significant improvements in overall aberrant behaviors and irritability.” “Data from this pilot investigation suggest that NAC is a safe and potentially effective in treating irritability and disruptive behaviors in children with autism.”
  • Homocysteine level in urine of autistic and healthy children. Kałużna-Czaplińska J, Michalska M, Rynkowski J.Acta Biochim Pol. 2011 Mar 11.
    "The higher level of homocysteine in autistic children may indicate deficiencies of folic acid and vitamins B6 and B12 in nutrition of these children."
  • Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N. PLoS One. 2011;6(5):e20470. Epub 2011 May 27.

 

2010 Articles of Interest: 

 

2009 Articles of Interest: 

2008 Articles of Interest:

 


James B. Adams, Ph.D, researcher at Arizona State University, conducted the clinical studies on Syndion. Dr. Adams is not affiliated with Yasoo Health and does not benefit financially from Syndion sales.  Click to visit Dr. Adams's research website.